glp 1 heart issues Can GLP-1 agonists treat cardiovascular diseases? Current and Emerging Roles of

24 : 4350 Toth E, Harsing LGJ, Sershen H, Ramacci MT, Lajtha A

Research published in Biochemical Pharmacology found that GLP-1 and estrogen share downstream signaling pathways

Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: A systematic review and meta-analysis

Arrange care when symptoms recur, persist despite simple changes, begin after a medicine adjustment, or occur with diarrhea, vomiting, pain, swallowing difficulty, weight loss, fever, anemia, or poor intake

Income, employment status, education level, and neighborhood resources all shape diabetes outcomes

This phase 1b/2a randomized, placebo-controlled trial enrolled 16 patients with type 2 diabetes and progressive DKD, who were allocated in a 3:1 ratio to receive either a single intravenous infusion of 80 106 ORBCEL-M cells (CD362-selected, allogeneic bone marrowderived MSCs) or placebo (253)